Yes, you can earn $75 to $300 participating in focus groups and attention studies specifically designed for people with ADHD. The compensation sits at the higher end of typical market research because these studies require specialized recruitment—researchers need participants with diagnosed ADHD who can provide authentic insights about attention, focus, and executive function challenges. For example, Civicom’s virtual focus groups pay $75–$150 for a standard 90-minute session, while in-person sessions range from $100–$300 depending on location and study duration. Additionally, clinical research trials related to ADHD treatment often exceed these amounts, with some Johns Hopkins Adult ADD/ADHD studies offering up to $300 plus travel reimbursement for multi-day participation.
Beyond standard focus groups, ADHD-specific clinical trials represent another compensation opportunity. These trials involve more intensive participation—sometimes lasting days or weeks—and can offer substantially higher payments. Some ADHD clinical trials compensate participants up to $715 total, combined with free medical care and transportation reimbursement. As of August 2025, 27 active ADHD clinical trials are recruiting participants across the United States, with concentrated opportunity in Florida, California, Texas, and the New York/Ohio region.
Table of Contents
- What Are ADHD-Focused Focus Groups and Why Do They Pay More?
- How Much Can You Actually Earn? Breaking Down the Payment Structure
- Where Are These Studies Concentrated and How Do You Find Them?
- What’s the Application and Screening Process Like?
- What Are the Risks and Limitations You Need to Know?
- Recent Developments in ADHD Research That Mean More Opportunities
- The Future of ADHD Research and Participant Compensation
- Conclusion
What Are ADHD-Focused Focus Groups and Why Do They Pay More?
ADHD-focused focus groups are market research sessions where companies, pharmaceutical firms, and researchers gather feedback specifically from people diagnosed with ADHD. These aren’t generic consumer panels—they’re targeted studies exploring how ADHD affects daily life, what treatments people use, how they manage work and relationships, and what products or services might help. Researchers pay premium rates because finding and recruiting qualified ADHD participants takes more effort than recruiting from the general population, and the data itself is more valuable. The compensation difference is significant. A standard online survey might pay $5–$15, while a general focus group pays $25–$75. ADHD-specific studies jump to $75–$300 because researchers need participants who can articulate their actual lived experience with attention problems, medication effects, or coping strategies.
Companies developing ADHD apps, productivity tools, or educational software will pay top rates for this input. Similarly, pharmaceutical companies testing ADHD medications or cognitive behavioral therapy programs need reliable feedback from people who actually live with the condition. The market itself is growing. The global ADHD market was valued at $14.3 billion in 2023 and is projected to reach $18.6 billion by 2030—a 3.7% annual growth rate. This expansion means more research funding, more clinical trials, and more focus groups. The U.S. alone has over 8.7 million adults diagnosed with ADHD, representing a huge pool of potential research participants and indicating strong ongoing investment in understanding and treating the condition.
How Much Can You Actually Earn? Breaking Down the Payment Structure
Focus group platforms like Plaza Research offer $75–$200 per session for studies lasting 60–$90 minutes, which translates to roughly $50–$130 per hour—solid compensation for sitting on a video call or in an office. Civicom, a major player in the focus group space, structures payments around format: virtual sessions pay $75–$150 for 90 minutes, while in-person groups pay $100–$300 depending on duration and location. In-person tends to pay more because you’re traveling and spending more time on-site. The catch is that not every study pays at the top of the range. A 60-minute online focus group might pay $75, while a 3-hour in-person session in a major city might pay $300. Qualification also matters—studies screening for specific ADHD severity levels, medication types, or comorbidities may have stricter eligibility requirements, which can reduce your chances of being selected.
If you participate in multiple studies with the same company, you may see recurring income, but there’s no guarantee of steady work. Clinical trials offer different economics. Johns Hopkins’ Adult ADD/ADHD studies pay up to $300 plus travel reimbursement for a 2-day outpatient study—meaning you could earn $300 for research while covering your transportation costs. Some trials go higher: certain ADHD treatment trials offer up to $715 in total compensation across the study period. The tradeoff is that clinical trials demand more time, more appointments, and more medical evaluation. You’ll have screening visits, baseline assessments, regular check-ins, and follow-up visits. This isn’t a one-time 90-minute meeting; it’s a weeks- or months-long commitment.
Where Are These Studies Concentrated and How Do You Find Them?
ADHD research funding and recruiting is geographically concentrated. States with the highest ADHD trial recruitment activity are Florida, California, Texas, and the new York/Ohio corridor. If you live in or near these areas, you’ll have significantly more opportunities than someone in a rural state. University medical centers and large healthcare systems in these regions run multiple concurrent ADHD studies, meaning a higher density of focus group and trial listings. National platforms like PolicyLab track active clinical trials by condition. As of August 2025, PolicyLab lists 27 active ADHD clinical trials recruiting participants. Government funding is supporting this pipeline: the National Institute of Mental Health (NIMH) committed $3 million in fiscal year 2026 to fund up to 4 awards for research specifically on optimizing treatment strategies for adult ADHD.
This funding translates directly into new studies and new recruitment—meaning there will be more opportunities opening up in the coming months. Finding these studies requires checking multiple sources. Large hospitals and academic medical centers have their own research volunteer databases. CHADD (Children and Adults with ADHD) maintains a research section on their website. Clinical trial registries like ClinicalTrials.gov let you search by condition and location. Focus group platforms like Civicom, Plaza Research, and others have online sign-up processes. However, a limitation is that smaller local studies may not be widely advertised—you may need to call local hospitals or university psychology departments to ask about unpublished recruiting efforts.
What’s the Application and Screening Process Like?
When you apply to a focus group or clinical trial, expect a multi-step screening process. Most focus group platforms start with a simple online questionnaire asking about your ADHD diagnosis, medications, work situation, and availability. Some ask you to confirm your diagnosis through medical records or a brief phone interview with a research coordinator. This step exists to verify you’re not misrepresenting your condition and that you match the study’s target population. Clinical trials involve more rigorous screening. Johns Hopkins and similar institutions require a formal diagnosis (usually confirmed through medical records), a baseline psychiatric assessment, sometimes lab work or imaging, and interviews with research staff. This thorough vetting takes 1–2 weeks and multiple visits before you’re officially enrolled.
The benefit is that once enrolled, your compensation is guaranteed, and you know exactly what you’re committing to. The downside is that screening can be disqualifying—if you have uncontrolled comorbid depression, substance use, or other medical conditions, you may be excluded to protect the study’s integrity and your safety. A practical consideration: focus groups often require you to be available at a specific time. If you’re offered a slot for Tuesday at 2 p.m. and can’t make it, you lose it. Clinical trials are more flexible because you book your appointments in advance during enrollment. If your ADHD symptoms fluctuate significantly—especially if you take medication that affects your ability to concentrate or sit still—focus groups that require sustained attention for 90 minutes might be harder than clinical trials where you’re expected to sit for assessments anyway.
What Are the Risks and Limitations You Need to Know?
One significant limitation is selection bias. Focus groups and clinical trials tend to recruit people with stable housing, reliable internet, and available time. If you’re working irregular shifts, lack transportation, or live in an area without research infrastructure, these opportunities become inaccessible. Additionally, people already engaged with treatment (on medication, in therapy) are overrepresented in research. If your ADHD is undiagnosed or untreated, recruiting criteria might exclude you—many studies require current diagnosis and treatment history. There’s also the risk of data privacy.
When you participate in an ADHD study, your health information goes into research databases. Most institutions follow strict HIPAA protocols, but your data could theoretically be breached or shared with third parties depending on the study consent form. Before enrolling, read the privacy section carefully—especially if the study involves a pharmaceutical company, which may access your data for drug development purposes. Additionally, some clinical trials carry medical risks. ADHD medication trials, in particular, might involve switching medications, adjusting dosages, or taking placebo, which could destabilize your current regimen. This is why medical screening is thorough—researchers want to enroll only people for whom the potential risks are acceptable.
Recent Developments in ADHD Research That Mean More Opportunities
In February 2026, a major collaborative review analyzing over 200 meta-analyses on ADHD treatments launched an interactive website helping people explore evidence-based treatment options. This kind of research infrastructure requires participant input, focus groups to understand real-world treatment decisions, and clinical trials to test new approaches. More rigorous treatment research means more funding, more studies, and more recruitment. The NIMH’s $3 million FY 2026 commitment to optimize adult ADHD treatment strategies represents institutional momentum behind ADHD research.
Additionally, CHADD’s Dr. Thomas E. Brown Pioneer Award, with 2026 applications due April 27, 2026, funds innovative ADHD research. These programs feed into a pipeline of new studies that will need participants. If you’re considering ADHD research participation, the next 12–18 months represent a high-opportunity window as this new funding becomes active grants and launches recruiting.
The Future of ADHD Research and Participant Compensation
The ADHD market’s projected growth to $18.6 billion by 2030 signals sustained investment in research and product development. More pharmaceutical companies are developing new ADHD medications, more tech companies are building ADHD-specific productivity tools, and more healthcare systems are studying treatment optimization. This expansion will sustain demand for focus groups and clinical trials featuring ADHD participants.
Compensation trends suggest rates will remain competitive or increase. As more companies recognize the value of ADHD-specific market research and as recruitment becomes more competitive, studies may need to offer higher rates to secure participants’ time. The current $75–$300 range for standard focus groups and up to $715 for clinical trials reflects the growing economic value of ADHD research. For people with ADHD seeking part-time income or willing to contribute to research that could improve treatment, the landscape is increasingly favorable.
Conclusion
Focus groups and clinical trials specifically targeting people with ADHD offer genuinely competitive compensation—$75–$300 for standard research sessions, with clinical trials often exceeding these amounts. The higher payment reflects both the specialized nature of ADHD research and the genuine value of your lived experience. Whether you participate in a one-time 90-minute virtual focus group or a multi-week clinical trial, these opportunities provide a way to contribute to better understanding of ADHD while earning meaningful income.
To get started, identify your location (Florida, California, Texas, and New York/Ohio have the most opportunities), check clinical trial registries, sign up with focus group platforms like Civicom and Plaza Research, and confirm you have documentation of your ADHD diagnosis. Read all screening requirements and consent forms carefully before committing. With 27 active ADHD trials recruiting and continued government funding for ADHD research, 2026 is an excellent time to explore these opportunities.
